Bioceres Crop Solutions Q1 2024 EPS $(0.04) Misses $0.06 Estimate, Sales $116.60M Miss $126.94M Estimate
Portfolio Pulse from Benzinga Newsdesk
Bioceres Crop Solutions (NASDAQ:BIOX) reported Q1 2024 earnings per share (EPS) of $(0.04), missing the analyst consensus estimate of $0.06. This represents a significant decrease from the $0.01 per share earned in the same period last year. Additionally, the company's quarterly sales of $116.60 million fell short of the expected $126.94 million, marking an 8.27% decline from the previous year's sales.
November 14, 2023 | 2:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bioceres Crop Solutions reported a significant miss in Q1 2024 EPS and sales, with a 500% decrease in earnings and an 8.27% decrease in sales compared to last year.
The missed earnings and sales estimates are likely to negatively impact investor sentiment in the short term. The magnitude of the miss, both in EPS and sales, suggests a significant underperformance compared to market expectations, which typically leads to a negative reaction in the stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100